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Abstract
Background: Pin 1 is a peptidyl-prolyl isomerase inhibitor related to cyclophilin A and FK506 binding protein
(FKBP). Juglone (5-hydroxy-1,4-naphthoquinone) is a natural inhibitor of Pin 1 with anti-inflammatory and
antifibrotic properties. We evaluated the role of Pin 1 in renal fibrogenesis by evaluating the effects of juglone on
epithelial to mesenchymal transition (EMT) and fibrogenesis in the rat unilateral ureteral obstruction (UUO) model
and normal rat tubular epithelial cells (NRK52E).
Results: After 2 weeks of UUO, immunoblot analyses demonstrated that juglone (0.25 and 1 mg/kg/24 h) inhibited
the deposition of matrix (a-smooth muscle actin (SMA), collagen type III and vimentin) and the activation of
signaling pathways involved in fibrogenesis (phospho-smad2) and stress response (phospho-heat shock protein
(HSP)27). Juglone also reduced EMT (a-SMA and E-cadherin dual staining) and oxidative stress (Mn superoxide
dismutase (SOD) and NAPDH oxidase 2 (Nox-2) dual staining) in the obstructed kidney. There was no difference in
Pin 1 levels between treatment and control groups. Pin 1 activity was significantly decreased in obstructed kidneys
regardless of treatment status. In vitro, juglone (1 μM) significantly decreased a-SMA and p-smad levels compared
to vehicle.
Conclusions: Juglone attenuates fibrogenesis via Pin 1-independent mechanisms in the UUO model. The
antifibrotic effects of juglone may result from the inhibition of smad2 and oxidative stress.
Background
Obstructive nephropathy is a major cause of renal fail-
ure, particularly in infants and children [1,2]. Urinary
tract obstruction and tubular dilatation result in a series
of proinflammatory events that ultimately lead to
chronic tubulointerstitial fibrosis and kidney failure
[1,2]. Fibrogenesis starts with the activation of the
renin-angiotensin system, tubular apoptosis and macro-
phage infiltration and is accompanied by the accumula-
tion of interstitial fibroblasts from either proliferation of
resident cells or epithelial to mesenchymal transition
(EMT) [1,2]. The rodent unilateral ureteral obstruction
(UUO) model has emerged as an important platform for
the study of complex cellular interactions that regulate
the development of interstitial inflammation, tubular
apoptosis and interstitial fibrosis in this milieu [3]. Evi-
dence suggests that the UUO model is reflective of
human kidney disease [3]. Studies examining the
mechanisms of fibrogenesis in UUO may therefore
result in the development of therapies that will prevent
or reverse the structural and functional consequences of
obstructive nephropathy [3].
Pin 1 is a cis-trans peptidyl-prolyl isomerase (PPIase)
related to cyclophilin A and FK506 binding protein
(FKBP) [4,5]. Pin 1 modulates cytokine expression by
activated T cells and eosinophils and participates in T
cell and eosinophil apoptotic decisions both in vitro and
in vivo [5]. In addition, Pin 1 blockade attenuates trans-
forming growth factor b 1( T G F b 1) and granulocyte-
macrophage colony-stimulating factor (GM-CSF) pro-
duction and inflammation in experimental models of
allergic lung fibrosis [4,6]. We therefore hypothesized
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this hypothesis in vivo u s i n gt h er o d e n tU U Om o d e l
and in vitro using normal rat proximal tubular epithelial
cells (NRK52E). We used juglone (5-hydroxy-1,4-
naphthoquinone) a natural inhibitor of Pin 1 to charac-
terize the effects of Pin 1 inhibition on fibrogenesis.
Results
Juglone reduced fibrogenesis after UUO
Male Lewis rats (3 months old) underwent UUO of the
left kidney for 2 weeks. There were three groups receiv-
ing vehicle, juglone 0.25 mg/kg/day or juglone 1 mg/kg/
day for 2 weeks starting the day of surgery. There was
no animal death associated with treatment. Treated ani-
mals had a 10% weight loss in the first week after sur-
gery, which resolved by the end of week 2. Immunoblot
analyses for Pin 1, biomarkers of matrix remodeling (a-
smooth muscle actin (SMA), collagen type III and
vimentin) and signaling pathways involved in fibrogen-
esis (phospho-smad2) and stress response (phospho-heat
shock protein (HSP)27) demonstrated that juglone ther-
apy decreased a-SMA, collagen type III, vimentin, p-
smad2 and p-HSP27 levels (Figure 1). There was no dif-
ference in Pin 1 levels between treatment and control
groups suggesting that juglone inhibits fibrogenesis
independently of Pin 1 levels in the UUO model.
Juglone and UUO had similar inhibitory effects on Pin 1
activity
We next examined Pin 1 activity in unobstructed and
obstructed kidneys in controlo rj u g l o n e - t r e a t e dr a t s .
These analyses would help us determine whether the
antifibrotic properties of juglone resulted from Pin 1
blockade. The studies demonstrated that juglone effec-
tively inhibited Pin 1 activity in unobstructed right kid-
neys (Figure 2). However, Pin 1 activity was significantly
decreased in left obstructed kidneys regardless of treat-
ment status (Figure 2). Pin 1 activity in obstructed kid-
neys was reduced to the same level as in unobstructed
kidneys treated with juglone. In aggregate, these studies
suggest that the antifibrotic effects of juglone are inde-
pendent from Pin 1 blockade during UUO.
Juglone reduced EMT and oxidative stress after UUO
To further define the effects of juglone on fibrogenesis,
we assessed EMT using double-staining immunohisto-
chemical analyses for E-cadherin (pink, epithelial mar-
ker) and a-SMA (brown, mesenchymal marker) in
normal right and UUO left kidneys in control or
juglone-treated rats (Figure 3a-c). These studies showed
pink basolateral E-cadherin staining in distal tubules of
control kidneys (Figure 3a). UUO resulted in downregu-
lation of E-cadherin (no basolateral staining) and greater
brown interstitial staining for a-SMA (Figure 3b). Treat-
ment with juglone preserved distal E-cadherin
Figure 1 Juglone reduced fibrogenesis after unilateral ureteral obstruction (UUO). Male Lewis rats (3 months old) underwent UUO of the
left kidney for 2 weeks. There were three groups receiving vehicle or juglone (0.25 mg/kg/day or 1 mg/kg/day) for 2 weeks starting the day of
surgery. (a) Immunoblot analyses of left kidney from control or juglone-treated rats for the proteins shown along the left. (b) Multiple (n = 3)
immunoblots were quantitated and signals expressed as arbitrary units after normalization to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) signal.
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u r e3 c ) ,s u g g e s t i n gt h a tj u g l o n em a ya t t e n u a t eE M T
during UUO. Aggregate semiquantitative scoring is pre-
sented as a bar graph in the right panel (Figure 3).
We evaluated oxidative stress using dual-staining ana-
lyses for antioxidant (Mn superoxide dismutase (SOD))
and pro-oxidant (NAPDH oxidase 2 (Nox-2)) enzymes
( F i g u r e3 d - f ) .M n S O Di sas u p e r o x i d es c a v e n g e rw h i l e
Nox-2 is one of the key generators of superoxide in the
kidney [7]. Normal kidneys showed strong tubular
MnSOD staining and rare patchy areas of monocytic
infiltration positive for Nox-2 (Figure 3d). UUO resulted
in reduced tubular MnSOD and increased tubulointer-
stitial Nox-2 (Figure 3e) consistent with significant
monocyte/macrophage infiltration and a pro-oxidant
milieu. Juglone attenuated these changes suggesting that
treatment decreases oxidative stress (Figure 3f). Consis-
tent with these findings, dihydroethidine staining for
superoxide anion was significantly decreased with
juglone compared to vehicle (Figure 3g, h). Aggregate
semiquantitative scoring is presented as a bar graph in
the right panel (Figure 3).
The effects of juglone on fibrogenesis may be mediated
by smad2
To determine whether juglone inhibited TGFb 1 activity
we evaluated phospho-smad2 activity in normal kidneys
compared to obstructed kidneys treated or not with
juglone (Figure 4). These studies demonstrated that
nuclear p-smad2 was significantly increased after UUO
and that juglone prevented nuclear p-smad2 activity.
Lastly, we evaluated the effects of juglone on a-SMA
and activated smad2 (p-smad2) levels in proximal tubu-
lar epithelial cells. Juglone (1 μM) significantly reduced
a-SMA and p-smad2 levels, consistent with our in vivo
studies and suggesting that juglone may inhibit smad2
phosphorylation and activation in tubular epithelial cells
(Figure 5).
Discussion
In the present work we demonstrate that juglone, a
naturally occurring Pin1 isomerase inhibitor, attenuates
Figure 2 Juglone and unilateral ureteral obstruction (UUO) had similar inhibitory effects on Pin 1 activity. Pin 1 activity was measured in
whole kidney protein lysates after 2 weeks of UUO as previously described [18]. Mean values and standard error bars from UUO and control
kidneys are represented for each time point.
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This effect appears to be Pin 1 independent as PPIase
activity was unchanged in the UUO left kidney between
control and juglone-treated rats. Our studies further
suggest that the antifibrotic effects of juglone result
from the inhibition of smad2 phosphorylation and oxi-
dative stress.
Juglone is a napthaquinone found in the leaves, roots
and bark of plants from the walnut family. It is toxic to
the growth of non-walnut plants and likely exerts its
effect by inhibiting peptidyl-prolyl isomerases found in
plants. Juglone has differential effects on cell cycling and
metabolism depending on the species, organ and drug
concentrations [8]. In F344 rats, high concentrations of
juglone-derived radioactivity were found in the kidney
after oral, intravenous and subcutaneous dosing [9]. The
accumulation in the kidney was attributed to covalent
binding of juglone and its metabolites to cytosolic pro-
teins and suggests that the kidney may be a potential
treatment target for juglone. In support of this hypoth-
esis, juglone increased the activities of phase II detoxifi-
cation enzymes quinone reductase and glutathione
transferase in the kidney of Sprague-Dawley rats
suggesting a role for this compound to protect animals
against toxin-induced kidney injury [10].
Our results are in agreement with previous observa-
tions addressing the antifibrotic and anti-inflammatory
characteristics of juglone in experimental models of
lung injury [6,11]. These studies demonstrated that
juglone therapy selectively inhibited eosinophilic and
lymphocytic inflammation in rats undergoing experi-
mental allergic lung fibrosis [6] and lung allograft rejec-
tion [11]. Juglone reduced eosinophilic pulmonary
inflammation, TGFb 1, collagen expression and airway
remodeling in rats undergoing allergic lung fibrosis [6].
Similarly, juglone treatment prevented the acute and
chronic rejection of major histocompatibility complex
(MHC)-mismatched, orthotopic rat lung transplants by
reducing the expression of proinflammatory interferon
(IFN)g and CXC chemokine ligand (CXCL)10 cytokines
[11]. In these studies, combined transcriptional and
post-transcriptional blockade of cytokine expression
with cyclosporine A and the juglone was synergistic
[11]. Our findings extend the s ed a t ab yd e m o n s t r a t i n g
that juglone also attenuates inflammation in a macro-
phage-driven kidney injury model [1-3].
Figure 3 Juglone reduced EMT and oxidative stress after unilateral ureteral obstruction (UUO). Right (control) and left (UUO) kidneys
were removed after 2 weeks, fixed and stained with antibodies for E-cadherin (pink, epithelial marker) and a-smooth muscle actin (SMA) (brown,
mesenchymal marker) to evaluate epithelial to mesenchymal transition (EMT), and Mn superoxide dismutase (MnSOD) (pink), NADPH odixase 2
(Nox-2) (brown) and superoxide (red fluorescent) to assess oxidative stress. Experimental conditions are shown along the top while antibody and
dyes that were utilized are along the left side of the panels. Aggregate semiquantitative scores are presented in the right panel. Cortical staining
intensity was scored on a scale of 0 to 3 (0 no staining, 1 mild, 2 moderate, 3 intense) for E-cadherin (distal tubules), a-SMA (interstitium),
MnSOD (tubules), Nox-2 (interstitium) and superoxide (tubulointerstitium). Five high magnification fields were evaluated per kidney (five kidneys
in each group) and results were expressed as mean and standard error bars.
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Page 4 of 8Figure 4 Juglone reduced nuclear smad2 activity in unilateral ureteral obstruction (UUO). Right (control) and left (UUO) kidneys were
fixed and stained with antibodies for phospho-smad2 (brown) to assess smad2 activity. Experimental conditions are shown along the top.
Aggregate semiquantitative scores are presented in the right panel.
Figure 5 The effects of juglone on fibrogenesis may be mediated by smad2. Proximal tubular cells were untreated, treated with vehicle, or
juglone as shown for 48 h prior to lysis and (a) western blotting for the proteins shown along the left. In (b), three independent experiments
were quantitated after normalization to actin signals.
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were not dependent on Pin 1 blockade in the UUO
model. Rather, they were associated with the inhibition
of oxidative stress and smad2 phosphorylation. Juglone
may have either pro or antioxidant characteristics
depending on the milieu and drug concentrations [8].
While its use can result in the generation of reactive
oxygen species in Caenorhabditis elegans [12], juglone is
a potent antioxidant in human cortical neurons [13].
Juglone treatment prevents oxidative and heat stress-
induced dephosphorylation of Tau (an important step in
the pathogenesis of Alzheimer’s disease) in primary
brain cortical cultures [13]. Oxidative stress is a com-
mon injury pathway involved in kidney fibrogenesis
[14,15]. We recently demonstrated that specific inhibi-
tors of Nox (the primary generator of superoxide anion
in the kidney) decreased fibrogenesis in kidney allografts
by decreasing fibronectin and phospho-smad2 and
increasing E-cadherin levels [7]. We have now demon-
strated that juglone improves the oxidative stress bal-
ance in the UUO model by downregulating Nox-2 and
superoxide anion while increasing tubular MnSOD
levels. In addition, we have shown that juglone inhibits
the phosphorylation of smad2 an important redox-sensi-
tive, profibrotic signaling molecule in the kidney
[7,16,17]. Although it is unclear whether the inhibition
of smad2 phosphorylation was a direct effect or a down-
stream event secondary to juglone’s antioxidant charac-
teristics in our model, smad2 inhibition has been
successful in experimental studies of native and trans-
plants kidney fibrosis [7,16,17].
Conclusions
In summary, these studies demonstrate that juglone
attenuates fibrogenesis in kidneys undergoing obstruc-
tive injury via Pin 1-independent mechanisms. The anti-
fibrotic effects of juglone may result from the inhibition
of inflammation and more specifically smad2 and oxida-
tive stress. Future studies are needed to determine the
cellular and molecular mechanisms that regulate the
inhibitory effects of juglone on smad and Nox
molecules.
Methods
Animals
Adult (9 to 11 weeks old) male Lewis rats were pur-
chased from Harlan Teklad (Madison, WI, USA). Ani-
mals were housed in the animal care facility at the
William Middleton Veterans Affairs Hospital (VAH) in
Madison, WI, USA, and the procedures were performed
in accordance with the animal care policies at the VAH
and the University of Wisconsin. The UUO procedure
was performed under general anesthesia with isoflurane
as described previously [14]. Briefly, the left ureter was
ligated with 6-0 silk at two points and then severed
between the ligatures to prevent retrograde urinary tract
infection. Control animals underwent surgery and
received vehicle (10% ethanol) (n = 5). Juglone was
administered intraperitoneally for 14 days at 0.25 (n =
5) and 1 mg/kg/24 h diluted in 1 ml of vehicle (n = 5).
Animals were killed after 2 weeks by exsanguination
through cardiac puncture under general anesthesia. Both
kidneys were harvested and sectioned longitudinally in
half. Half was snap frozen immediately and used for
immunoblot analysis and the other half was formalin
fixed and paraffin embedded for immunohistochemical
analyses. The right kidney served as the control to the
left obstructed kidney.
Immunoblotting
Western blotting was performed on protein lysates
obtained from whole kidney tissue or cell lysates as
described previously [14]. Briefly, after separation by
SDS-PAGE (10% to 20% gradient PAGE, Bio-Rad, Her-
cules, CA, USA) proteins were transferred electrophore-
tically (100 V, 30 min) to nitrocellulose membranes
(Bio-Rad) that were then blocked with a solution con-
taining 5% non-fat milk, 50 mM Tris, HCl, pH 7.4,
NaCl 150 mM, Tween 20 0.05% (TBS-Tween) overnight
at 4°C. Membranes were incubated the next day with
antibodies against a-SMA (2,000
-1), Vimentin (100
-1),
collagen type III (100
-1), phospho-HSP27 (0.25
-1), phos-
pho-smad2 (2,500
-1), Pin 1 (200
-1), and GAPDH
(1:5,000). Binding of primary antibodies was followed by
incubation for 1 h at room temperature with a second-
ary horseradish peroxidase (HRP)-conjugated IgG in 1%
non-fat milk. Signals were visualized by enhanced che-
miluminescence signals captured on x-ray films. Data
was normalized to GAPDH. Densitometry was per-
formed using the NIH Image J software http://rsbweb.
nih.gov/ij/.
Immunohistochemical analyses
A portion of the kidney tissue was excised promptly
after the animals were killed. It was immediately placed
in 10% neutral-buffered formalin. Tissue was fixed over-
night in formalin and processed for paraffin embedding
following standard protocols and then sectioned for
antibody staining. Double staining of E-cadherin/a-SMA
and Nox-2/MnSOD was performed after sections were
deparaffinized and hydrated. Heat-induced antigen
retrieval was performed using a 5 mM ethylenediamine-
tetra-acetic acid (EDTA) solution (pH = 8.0) and a 10
mM citrate solution (pH = 6.0), respectively, at 25 psi
for 2 min in a decloaking chamber. Non-specific stain-
ing was blocked using Sniper (Biocare Medical, Con-
cord, CA, USA) for 9 min. Slides were incubated
overnight with p-smad2 (500
-1), E-cadherin (50
-1)o r
Nox-2 (50
-1) then washed and incubated with 3% hydro-
gen peroxide for 30 min. MACH 2 HRP polymer
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and 3,3’-diaminobenzidine (DAB) substrate were used to
tag and stain the first primary antibody brown. Slides
were then incubated with the second primary antibody
a-SMA (50,000
-1)o rM n S O D( 5 , 0 0 0
-1)a tr o o mt e m p
for 1 h. MACH 2 HRP polymer detection system and
VIP substrate (Vector Laboratories, Burlingame, CA,
USA) were used to tag and stain the second primary
antibody purple. Tissue sections were washed in distilled
water, counterstained with hematoxylin, dehydrated
through an ethanol series and mounted with cover slips.
Harris hematoxylin and 1% alcohol eosin were used to
assess overall kidney injury and morphology. A total of
25 μM dihydroethidine dye (Molecular Probes, Carlsbad,
CA, USA) was used for superoxide anion staining
according to the manufacturer’s recommendations.
Cortical staining intensity was scored on a scale of 0
to 3 (0 no staining, 1 mild, 2 moderate, 3 intense) for E-
cadherin (distal tubules), a-SMA (interstitium), MnSOD
(tubules), Nox-2 (interstitium), p-smad2 and superoxide
(tubulointerstitium). Five high magnification fields were
evaluated per kidney and results were expressed as
mean and standard error bars.
Pin 1 activity assay
Pin 1 activity was measured in whole kidney protein
lysates as described previously [18]. Briefly, tissue lysates
were prepared by five freeze-thaw cycles in a buffer con-
taining 50 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES) and 100 mM NaCl (pH 7.0).
Total protein (10 μg) in 10 μlw a sm i x e dw i t h7 0μlo f
the HEPES/NaCl buffer supplemented with 2 mM
dithiothreitol (DTT) and 0.04 mg/ml bovine serum
albumin (BSA). Then, 5 μl of chymotrypsin (60 mg/ml
in 0.001 N HCl) was added and thoroughly mixed.
Finally, 5 μl of the substrate Suc-AEPF-pNa (provided
by Peptides International, Louisville, KY, USA) dissolved
in dimethyl sulfoxide (DMSO) and prepared at 100 μg/
ml in 480 mM LiCl/trifluoroethanol was added. The
absorption at 390 nM, which detects the formation of
free p-nitroanilide (pNA), was monitored using a Beck-
man Coulter
DU 800 spectrophotometer (Brea, CA, USA). All of
the reagents and materials were kept at 4°C during the
procedure. Mean values and standard error bars from
UUO and control kidneys are represented for each time
point.
Juglone in vitro experiments
Normal rat kidney proximal epithelial cells (NRK52E)
were obtained from the American Type Culture Collec-
tion (ATCC, Rockwell, MD, USA) and maintained at 37°
C in a humidified atmosphere containing 5% CO2. Cells
were seeded at 2.5 × 10
5 cells per well into six-well cul-
ture plates in Dulbecco modified Eagle medium
(DMEM; high glucose) containing 5% heat inactivated
fetal bovine serum (FBS), 44 mM NaHCO3, 5,000 IU
penicillin and 5,000 μg/ml streptomycin (Cellgro, VA,
USA). At 80% confluency, media was changed to serum
free DMEM supplemented with 0.1% BSA for 12 h to
arrest growth and synchronize cell activity. Cells were
treated with juglone (1 μM) or vehicle (0.01% ethanol)
for 48 h. Studies were performed in triplicates. Western
blots for a-SMA, phospho-smad2 and b-actin were per-
formed as described above.
Statistical analysis
The Student t test and the non-parametric Mann-Whit-
ney rank sum test (Sigma Stat Software, Jandel Scienti-
fic, Chicago, IL, USA) were utilized when appropriate to
compare differences in Pin 1 activity and gene and pro-
tein expression between groups. P values ≤ 0.05 were
considered significant.
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